Higher or Lower Dose Cladribine, Cytarabine, and Mitoxantrone in Treating Medically Less Fit Patients With Newly Diagnosed Acute Myeloid Leukemia or Myeloid Neoplasm
Clinical trial NCT03012672 · COMPLETED
Trial details
- NCT number
- NCT03012672
- Sponsor
- University of Washington
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-12-30
- Primary completion
- 2020-12-10
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.